SCHEMBL5273682

SCHEMBL5273682

Cc1ccc(-c2nncs2)cc1-c1ccc(C(N)=O)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.41
BTK Q06187 1/20 0.39
S1PR2 O95136 1/20 0.38
S1PR4 O95977 1/20 0.38
HPGD P15428 1/20 0.37
EPHX2 P34913 1/20 0.36
IL2 P60568 3/20 0.36
MAPK14 Q16539 2/20 0.35
MAPK11 Q15759 1/20 0.35
RAB9A P51151 2/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B1 P14061 3/20 0.35
HSD17B2 P37059 3/20 0.35
FGFR3 P22607 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5273688 0.81 TSHR (0.36) IL2RAB9AALDH1A1KDRTSHR
SCHEMBL5268576 0.81 CHEK2 (0.47) IKBKBBTKS1PR2S1PR4HPGD
SCHEMBL5269931 0.81 CHEK1 (0.47) IKBKBBTKS1PR2S1PR4HPGD
SCHEMBL5274012 0.79 ALDH1A1 (0.42) IKBKBBTKS1PR2S1PR4HPGD
SCHEMBL5273156 0.76 IKBKB (0.43) IKBKBBTKS1PR2S1PR4HPGD
SCHEMBL5550520 0.74 GSK3B (0.39) IL2FGFR3KDRGSK3BDYRK1A
SCHEMBL5275242 0.74 IKBKB (0.41) IKBKBBTKS1PR2S1PR4HPGD
SCHEMBL5271637 0.74 IL2 (0.58) IKBKBBTKS1PR2S1PR4HPGD
SCHEMBL5271715 0.73 LMNA (0.40) IKBKBBTKS1PR2S1PR4HPGD
SCHEMBL5270986 0.73 IL2 (0.54) IL2GSK3BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8802721-B2 Thiophene compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2014-08-12 US claimed
EP-1846388-A1 THIOPHENE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES Synta Pharmaceuticals Corporation (US) 2007-10-24 EP claimed
US-20060199845-A1 Thiophene compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2006-09-07 US claimed
WO-2006081389-A1 THIOPHENE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2006-08-03 WO claimed
US-8802721-B2 Thiophene compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2014-08-12 US disclosed
EP-1846388-A1 THIOPHENE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES Synta Pharmaceuticals Corporation (US) 2007-10-24 EP disclosed
US-20060199845-A1 Thiophene compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2006-09-07 US disclosed
WO-2006081389-A1 THIOPHENE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2006-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060199845-A1 Thiophene compounds for inflammation and immune-related uses CXCR2, TPMT, CXCR1 IKBKB 2112/4885BTK 119/4885S1PR2 776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.